Bradford B. Worrall, MD, a University of Virginia professor of neurology and public health, says many stroke survivors develop spasticity.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigin ...